Teva Pharmaceutical Industries Ltd ADR buy The Goldman Sachs Group, Inc.
Start price
08.12.25
/
50%
€24.40
Target price
08.12.26
€26.60
Performance (%)
13.11%
Price
09.01.26
€27.60
Summary
This prediction is currently active. The prediction currently has a performance of 13.11%. This prediction currently runs until 08.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 4.545% | 4.545% |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $28.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€25.90
19.12.25
19.12.25
€29.84
19.12.26
19.12.26
6.56%
09.01.26
09.01.26
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€15.15
06.06.25
06.06.25
€20.97
06.06.26
06.06.26
82.18%
09.01.26
09.01.26